Trial Profile
Intermittent Mupirocin to Prevent Staphylococcal Infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2018
Price :
$35
*
At a glance
- Drugs Mupirocin (Primary) ; Polyethylene glycol
- Indications Staphylococcal infections
- Focus Therapeutic Use
- 25 Jan 2013 Actual end date changed from Mar 2010 to Aug 2012 as reported by ClinicalTrials.gov.
- 28 Jun 2010 Actual end date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 28 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.